Squarepoint’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
284,567
+268,572
| +1,679% | +$1.25M | ﹤0.01% | 1362 |
|
|
2025
Q1 | $87.8K | Sell |
15,995
-24,774
| -61% | -$136K | ﹤0.01% | 2548 |
|
|
2024
Q4 | $138K | Buy |
40,769
+22,084
| +118% | +$74.9K | ﹤0.01% | 2473 |
|
|
2024
Q3 | $53.3K | Buy |
+18,685
| New | +$53.3K | ﹤0.01% | 2429 |
|
|
2022
Q3 | – | Sell |
-11,651
| Closed | -$18K | – | 2585 |
|
|
2022
Q2 | $18K | Sell |
11,651
-121,799
| -91% | -$188K | ﹤0.01% | 2029 |
|
|
2022
Q1 | $342K | Buy |
133,450
+119,567
| +861% | +$306K | ﹤0.01% | 1662 |
|
|
2021
Q4 | $41K | Buy |
13,883
+1,288
| +10% | +$3.8K | ﹤0.01% | 2438 |
|
|
2021
Q3 | $31K | Sell |
12,595
-20,008
| -61% | -$49.2K | ﹤0.01% | 2144 |
|
|
2021
Q2 | $133K | Buy |
+32,603
| New | +$133K | ﹤0.01% | 2363 |
|
|
2020
Q3 | – | Sell |
-45,809
| Closed | -$122K | – | 2727 |
|
|
2020
Q2 | $122K | Buy |
45,809
+28,973
| +172% | +$77.2K | ﹤0.01% | 1897 |
|
|
2020
Q1 | $33K | Buy |
+16,836
| New | +$33K | ﹤0.01% | 1746 |
|